Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Adaptam Therapeutics Raises €3M Pre-Seed Round Led by Criteria Bio Ventures
SeedVenture Capital

Adaptam Therapeutics Raises €3M Pre-Seed Round Led by Criteria Bio Ventures

•October 27, 2025
•Oct 27, 2025
0

Participants

Adaptam Therapeutics

Adaptam Therapeutics

company

Criteria Bio Ventures

Criteria Bio Ventures

investor

Deal Summary

Adaptam Therapeutics, a San Sebastián-based biotech focused on cancer immunotherapies targeting immunosuppressive myeloid cells, closed a €3M (~$3.5M) pre-seed financing round led by Criteria Bio Ventures. Representatives from Criteria Bio Ventures joined Adaptam's board as part of the transaction.

0

Comments

Want to join the conversation?

Loading comments...